Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Keratosis, Actinic 1Dermatitis, Contact 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1

Interventions

HhAntag691 18Imiquimod 10sonidegib 8Photochemotherapy 71-phenyl-3,3-dimethyltriazene 6methyl 5-aminolevulinate 4Surgical Procedures, Operative 4Biopsy 4Aminolevulinic Acid 4cemiplimab 3Mohs Surgery 3Microscopy, Confocal 3Itraconazole 3IPI-926 33-ingenyl angelate 3tazarotene 2Microarray Analysis 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2Drug Evaluation 2Acitretin 2tozuleristide 1teriflunomide 1talimogene laherparepvec 1silmitasertib 1remetinostat 1pembrolizumab 1gusacitinib 1green tea extract polyphenone E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Basal Cell × Triamcinolone × Clear all
NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡